Back to Top Skip to main content

Understanding the potential of COVID-19 convalescent plasma

Researcher scans a unit of plasma in lab. U.S. Army Sgt. Reginald Miles labels donated liquid plasma at the Landstuhl Blood Donor Center. Researchers are studying COVID-19 convalescent plasma to harness the power of neutralizing antibodies to help patients. (Photo by Volker Ramspott)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program | Armed Services Blood Program

The Department of Defense has set a goal to collect more than 8,000 donated units of plasma from patients who have recovered from COVID-19 by Sept. 30, 2020. This blood will be used to treat critically ill patients and support the development of an effective treatment against the disease.

Like a missile locking on its target, antibodies attack invaders inside the body with a singularity of purpose: search and destroy. Typically, infection-fighting white blood cells produce antibodies as an appropriate response to an invading germ. In some people whose immune systems can’t mount a sufficient attack against a virus, donated antibodies from another person’s plasma may help. Researchers believe the power of antibodies lies in their ability to bind to a virus and neutralize it, or block it from entering cells, said Dr. Kayvon Modjarrad, director of the Emerging Infectious Diseases Branch at the Walter Reed Army Institute of Research in Silver Spring, Maryland. Modjarrad leads the Army’s COVID-19 vaccine development research.

But not all antibodies are created the same. “Antibodies come in different flavors, some of them are neutralizing and some of them are non-neutralizing and we don’t know exactly which individuals are developing what type of antibody,” said Shelly Krebs, chief of B Cell Biology Core at WRAIR Military HIV Research program.

COVID-19 convalescent plasma, or CCP, from a recovered patient could be a mixture of both neutralizing and non-neutralizing antibodies. In fact, people infected with COVID-19 can have varying antibody responses. Some may not have enough antibodies in their plasma to benefit another patient, which is why CCP first needs to be tested for neutralizing antibody levels before transfusing, explained Modjarrad. His lab works to understand the mechanism of COVID-19 antibodies to predict the levels required to offer a person protection from the virus.

Transfusing antibodies provides short-term immunity as the donor antibodies last several weeks to months inside the body, said Navy Capt. (Dr.) Todd Gleeson of the Navy Bloodborne Infection Management Center, located at Naval Support Activity Bethesda, Maryland. “It is likely that a person with COVID-19 who receives CCP will also still develop their own immune cells and produce antibodies to fight the virus if that person is re-exposed in the future,” said Gleeson, who leads a convalescent plasma study of patients at Walter Reed National Military Medical Center also at NSAB in Bethesda. But scientists just can’t confirm that yet. They hope to uncover the answer and many more as they study CCP and COVID-19 antibodies to better treat patients and develop future vaccines.

Military medical treatment facilities will soon take part in an observational study across the Department of Defense to help researchers track trends among patients with COVID-19. The data will help trace recovered patients to ask for CCP donations as the DoD seeks to build a storehouse of CCP for patients admitted to Military Health System facilities and those deployed outside the U.S., explained Army Col. (Dr.) Andrew Cap, director of research at the Army Institute of Surgical Research in San Antonio, Texas. “The goal is to build a convalescent plasma capability within the DoD, both on the collection and on the treatment side,” said Cap, who helped draft a CCP protocol for the DoD.

Future research may lead to the development of highly concentrated neutralizing antibodies extracted from large quantities of convalescent plasma as a potential therapy for prevention and treatment, added Cap.

Scientists believe monoclonal antibodies—derived from a single immune cell—may also hold potential as both a treatment and preventive measure against COVID-19. Krebs and her team have engineered monoclonal antibodies in the lab by isolating the best neutralizing antibodies from CCP samples to create an army of exact replicas that target the COVID-19 virus down to the atomic level, explained Modjarrad. “We know where and how well it’s going to target, and we know the kinetics of how long it will last in the body and how long it will provide protection,” he explained, noting convalescent plasma does not provide that level of effectiveness. “CCP is not generally used for prevention but for treatment.” Monoclonal antibodies could be used for both treatment and prevention of COVID-19 because the transfused neutralizing antibodies would provide immediate immunity, he added.

Monoclonal antibodies have been in use for decades and revolutionized cancer treatment. Krebs’ lab plans to expand the research into monoclonal antibodies against COVID-19 into animal studies this summer. “Our primary goal is to come up with a treatment for people who have COVID-19,” she said.

Anyone able to donate convalescent plasma should contact the Armed Services Blood Program or go online to find a complete list of available collection centers.

You also may be interested in...

New Navy units join in the fight against COVID-19

Article
8/7/2020
Military nurse putting on PPE

This deployment marked the first use of the newly established Acute Care Team and Rapid Rural Response Team medical platforms.

Recommended Content:

Coronavirus

Air Force updates medical courses with COVID-19 content, procedures

Article
8/7/2020
Two lab technicians wearing full PPE handling vials for testing

COVID-19 has pushed instructors and trainers to be more innovative.

Recommended Content:

Coronavirus | Health Readiness | Combat Support

BAMC nurses: “It’s us against COVID”

Article
8/6/2020
Group of nurses at a hospital

With safety on the line, mistakes aren’t an option when it comes to PPE.

Recommended Content:

Coronavirus

Madigan collects CCP in fight against COVID-19

Article
8/6/2020
Four people in a hospital room wearing masks

Convalescent plasma has been used for nearly a century to transfer antibodies from a recovered person to help protect another from an infection.

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

DHA to recognize COVID-19 front-line innovators and leaders

Article
8/5/2020
Hospital Corpsman administers a COVID-19 test to service member aboard the Wasp-class amphibious assault ship USS Essex.

Who are the COVID-19 change makers?

Recommended Content:

Coronavirus | Patient Safety | Patient Safety Champion Recognition Program

Indiana National Guard continues to train in the COVID-19 environment

Article
8/5/2020
Soldiers in the field, wearing masks and testing equipment

Training in a time of COVID-19

Recommended Content:

Coronavirus | Health Readiness

MHS asks COVID-19 recovered to donate plasma for seriously ill

Article
8/4/2020
Woman wearing mask and PPE holding a bag of plasma

Plasma donations needed in the fight against COVID-19

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

MTFs plan and prepare to face any emergency or disaster

Article
8/4/2020
Hospital personnel surrounding a patient

Military hospitals make emergency plans and conduct practice drills long before a natural disaster strikes.

Recommended Content:

Coronavirus | Emergency Preparedness and Response

Air Force mental health team provides for deployed troops

Article
8/4/2020
U.S. Air Force Tech. Sgt. Nathan Davis, conducts a weekly Disaster Mental Health battlefield circulation walk around Quarantine Town.

The Disaster Mental Health team helps combat the stressors of the novel coronavirus and improves the overall well-being of service members of Al Udeid Air Base in Qatar.

Recommended Content:

Mental Health Care | Mental Wellness | Coronavirus

DoD leadership updates Pentagon on COVID-19 testing capabilities

Article
8/3/2020
Image of Air Force Maj. Gen. (Dr.) Lee Payne speaking, with Pentagon sign behind him

How COVID-19 testing helps prevent spread of the virus

Recommended Content:

Coronavirus

Army Medicine leaders visit BACH’s COVID-19 frontlines

Article
8/3/2020
Soldier in mask speaking to other soldiers

The commander shared both successes and challenges in the face of a global pandemic.

Recommended Content:

Coronavirus

Air Force medical technician drawn to caring for others

Article
7/31/2020
Woman in white chemical suit

"As a medic, my job is to test people for the virus to help make sure they’re safe."

Recommended Content:

Coronavirus

In this Together: Military Couple Recovers from COVID-19, Donates Convalescent Plasma

Article
7/30/2020
Couple wearing masks, holding bags of plasma

There is information that suggests CCP might help some patients recover from the disease.

Recommended Content:

Armed Services Blood Program | Coronavirus | Convalescent Plasma Collection Program

Military Health System experts discuss COVID-19 innovations

Article
7/30/2020
Four men wearing masks, holding COVID-19 Airway Management Isolation Chamber

How quick thinking and new approaches are saving lives in the pandemic fight.

Recommended Content:

Coronavirus | July Toolkit

DoD COVID-19 Practice Management Guide Version 5

Technical Document
7/30/2020

This Practice Management Guide does not supersede DoD Policy. It is based upon the best information available at the time of publication. It is designed to provide information and assist decision making. It is not intended to define a standard of care and should not be construed as one. Neither should it be interpreted as prescribing an exclusive course of management. It was developed by experts in this field. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of this guideline is responsible for evaluating the appropriateness of applying it in the setting of any particular clinical situation. The Practice Management Guide is not intended to represent TRICARE policy. Further, inclusion of recommendations for specific testing and/or therapeutic interventions within this guide does not guarantee coverage of civilian sector care. Additional information on current TRICARE benefits may be found at www.tricare.mil or by contacting your regional TRICARE Managed Care Support Contractor.

Recommended Content:

Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 17

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.